Genzyme Hits Roxane With Suit Over Hectorol ANDA

Law360, New York (August 3, 2009, 6:32 PM EDT) -- Biotechnology company Genzyme Corp. has sued a fourth competitor, Roxane Laboratories Inc., for patent infringement in an effort to fend off efforts to market generic versions of the dialysis drug Hectorol.

Cambridge, Mass.-based Genzyme filed a complaint Friday in the U.S. District Court for the District of Delaware, seeking preliminary and permanent injunctions against Roxane from making or selling a generic version of Hectorol in the U.S. until the patent and any other rights have expired.

The company is also asking for damages if Roxane sells...
To view the full article, register now.